Drug Industry Daily
Aug. 3, 2012
| Vol.
11 No.
152
Tentative Settlement Reached in Risperdal Marketing Case, J&J Says
Johnson & Johnson (J&J) has a reached an agreement in principle with federal prosecutors to settle off-label marketing matters pending in three states, J&J said in an SEC filing Thursday.
This article is viewable by subscribers only. To view this article, please select an option below.
|